ORIC Pharmaceuticals, Inc. (ORIC) Insider Trading
Over the last 3 months, ORIC insiders made 0 open-market buys and 3 sales, a net sale of -$161K (SEC Form 4). Over the last 6 months, 129 institutions increased and 98 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
3
Net (3m)
-$161.1K
Insider trades by month Buys Sells
Sep
Oct
Dec
Jan
Feb
Jul
Context3-month price +14.2%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 28, 2026 | Heyman Richard A.director | Option | 3,500 | $1.60 |
| Jul 28, 2026 | Heyman Richard A.director | Sell | 7,000 | $12.02 |
| Jul 28, 2026 | Heyman Richard A.director | Sell | 6,100 | $12.02 |
| Jul 8, 2026 | Heyman Richard A.director | Sell | 300 | $12.00 |
| Feb 26, 2026 | Piscitelli Dominicofficer: Chief Financial Officer | Sell | 52,000 | $13.51 |
| Feb 26, 2026 | Piscitelli Dominicofficer: Chief Financial Officer | Option | 52,000 | $4.36 |
| Jan 20, 2026 | Heyman Richard A.director | Sell | 3,200 | $12.00 |
| Jan 20, 2026 | Heyman Richard A.director | Sell | 3,500 | $12.00 |
| Jan 6, 2026 | Chacko Jacobdirector, officer: PRESIDENT AND CEO | Grant | 112,500 | — |
| Jan 6, 2026 | Heyman Richard A.director | Grant | 40,000 | $8.17 |
| Jan 6, 2026 | Hoerter Steven L.director | Grant | 40,000 | $8.17 |
| Jan 6, 2026 | Kunkel Lori Annedirector | Grant | 40,000 | $8.17 |
| Jan 6, 2026 | You Angiedirector | Grant | 40,000 | $8.17 |
| Jan 6, 2026 | Piscitelli Dominicofficer: Chief Financial Officer | Grant | 206,500 | $8.17 |
| Jan 6, 2026 | Piscitelli Dominicofficer: Chief Financial Officer | Grant | 34,500 | — |
| Jan 6, 2026 | Dier Mardidirector | Grant | 40,000 | $8.17 |
| Jan 6, 2026 | Multani Pratik Sofficer: Chief Medical Officer | Grant | 214,000 | $8.17 |
| Jan 6, 2026 | Multani Pratik Sofficer: Chief Medical Officer | Grant | 35,500 | — |
| Jan 6, 2026 | Chacko Jacobdirector, officer: PRESIDENT AND CEO | Grant | 675,000 | $8.17 |
| Dec 17, 2025 | Piscitelli Dominicofficer: Chief Financial Officer | Option | 29,333 | — |
| Dec 17, 2025 | Piscitelli Dominicofficer: Chief Financial Officer | Option | 11,333 | — |
| Dec 17, 2025 | Piscitelli Dominicofficer: Chief Financial Officer | Option | 10,000 | — |
| Dec 17, 2025 | Piscitelli Dominicofficer: Chief Financial Officer | Option | 8,000 | — |
| Dec 17, 2025 | Chacko Jacobdirector, officer: PRESIDENT AND CEO | Option | 83,666 | — |
| Dec 17, 2025 | Chacko Jacobdirector, officer: PRESIDENT AND CEO | Sell | 33,374 | $9.06 |
| Dec 17, 2025 | Chacko Jacobdirector, officer: PRESIDENT AND CEO | Option | 33,333 | — |
| Dec 17, 2025 | Chacko Jacobdirector, officer: PRESIDENT AND CEO | Option | 28,333 | — |
| Dec 17, 2025 | Chacko Jacobdirector, officer: PRESIDENT AND CEO | Option | 22,000 | — |
| Dec 17, 2025 | Multani Pratik Sofficer: Chief Medical Officer | Option | 29,333 | — |
| Dec 17, 2025 | Multani Pratik Sofficer: Chief Medical Officer | Option | 11,333 | — |
Source: ORIC SEC Form 4 filings, latest Jul 28, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their ORIC positions over the last 6 months (SEC Form 13F).
Increased
129
New positions
71
Reduced
98
Sold out
48
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| NEXTECH INVEST, LTD. | Unchanged | 7.2M | May 15, 2026 |
| NEXTECH INVEST, LTD. | Unchanged | 7.2M | Feb 17, 2026 |
| ECOR1 CAPITAL, LLC | Unchanged | 6.7M | Feb 17, 2026 |
| ECOR1 CAPITAL, LLC | Unchanged | 6.7M | May 15, 2026 |
| VIKING GLOBAL INVESTORS LP | Reduced | 6.6M | Feb 17, 2026 |
| BLACKROCK, INC. | Increased | 6.0M | May 13, 2026 |
| BLACKROCK, INC. | Increased | 5.9M | Feb 12, 2026 |
| VIKING GLOBAL INVESTORS LP | Reduced | 5.8M | May 15, 2026 |
| VR ADVISER, LLC | Reduced | 5.7M | Feb 17, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 5.4M | May 15, 2026 |
| PFIZER INC | Unchanged | 5.4M | Feb 12, 2026 |
| PFIZER INC | Reduced | 4.8M | May 12, 2026 |
| VANGUARD GROUP INC | Reduced | 4.5M | Jan 29, 2026 |
| SR ONE CAPITAL MANAGEMENT, LP | Unchanged | 4.5M | Feb 12, 2026 |
| SR ONE CAPITAL MANAGEMENT, LP | Unchanged | 4.5M | May 14, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.